Kimberly-Clark Earnings Call Transcripts
Fiscal Year 2026
-
A major transformation has driven strong organic growth, margin expansion, and innovation-led market share gains. The Powering Care strategy, digital transformation, and operational excellence position the company for accelerated growth and value creation, especially with the Kenvue acquisition closing in 2026.
-
Stockholders approved the issuance of common stock as part of a merger agreement, with final results to be filed with the SEC. Only the issuance proposal was considered, and questions from stockholders will be answered by email.
Fiscal Year 2025
-
Delivered strong volume-plus-mix growth and share gains in key markets, with 2026 guidance targeting margin expansion, innovation-driven growth, and resilience despite competitive and channel headwinds. Kenvue acquisition and productivity gains are expected to further enhance performance.
-
Powering Care strategy drove innovation-led growth, margin expansion, and strong cash flow in 2025, with continued momentum into 2026. Pending Kenvue acquisition and joint venture with Suzano are expected to accelerate growth, deliver synergies, and enhance shareholder value.
-
The conference detailed the strategic rationale for acquiring Kenvue, emphasizing synergy opportunities, operational efficiency, and portfolio complementarity. Management outlined robust integration plans, a disciplined approach to brand and portfolio management, and confidence in delivering top-tier growth and margins post-deal.
-
A transformational merger will create a global health and wellness leader with $32B in annual revenue and $7B in EBITDA, leveraging complementary portfolios and geographic strengths. The deal, valued at $48.7B, targets $2.1B in synergies and is expected to close in H2 2026, with a focus on innovation, operational discipline, and long-term value creation.
-
Delivered strong Q3 results with continued volume plus mix-led growth and margin expansion, driven by innovation and premiumization across all channels. Outlook remains positive, with margin targets and EPS growth expected post-IFB transaction.
-
Transformation momentum continues with Q3 organic net sales up 2.5% and strong productivity gains. Despite headwinds from divestitures, tariffs, and currency, the business is on track for low single-digit profit and EPS growth for 2025.
-
Transformation to a consumer-focused, higher-margin portfolio is accelerating progress toward 2030 targets, with reduced earnings volatility and strong productivity gains. Increased digital marketing and innovation are driving brand growth and market share, while cost savings and operational improvements support a positive financial outlook.
-
The company is advancing its transformation into a focused personal care and wellness leader, accelerating innovation, premiumization, and digital brand building. Strong productivity, portfolio reshaping, and global execution are driving growth, with financial targets on track and further gains expected as new strategies and partnerships take hold.
-
Second quarter results showed strong organic sales growth, robust volume, and global share gains, driven by innovation and effective portfolio focus. Outlook remains positive with continued volume/mix-led growth, increased brand investment, and improved margin targets.
-
Management highlighted progress in growth, innovation, and operational efficiency, with a focus on premiumization and global supply chain improvements. Despite category slowdown and tariff impacts, guidance remains volume and mix-driven, with continued investment in innovation and brand building.
-
The meeting highlighted a strong 2024 performance, exceeding growth targets and returning $2.6 billion to shareholders. All board nominees and proposals were approved, and strategic transformation initiatives were advanced.
-
Q1 results were in line with profitability expectations but organic sales growth lagged due to softer category growth, fewer shipping days, and tariff headwinds. Guidance was revised to flat EPS and operating profit, with continued investment in innovation and supply chain transformation.
Fiscal Year 2024
-
Delivered strong 2024 results with margin expansion, robust productivity savings, and market share gains in key regions. 2025 outlook calls for volume and mix-led growth, continued cost discipline, and further margin improvement, with even phasing across the year.
-
A new matrixed organization and supply chain transformation are driving productivity and innovation, with volume-plus-mix-led growth expected at the lower end of 2%-3%. Strategic exits and divestitures will create short-term headwinds but are aimed at sustainable, brand-focused growth.
-
Gross margin expanded to 37% YTD, with strong productivity and brand investment offsetting headwinds from inventory reductions and private label exits. Category growth is resilient but expected at the lower end of guidance, with further focus on premiumization and operational agility.
-
A new balanced matrix structure is being implemented with strong employee support and early operational benefits, especially in supply chain efficiency. The company targets $3B in productivity savings, increased advertising, and innovation-driven growth, while continuously optimizing its portfolio for long-term value.
-
Strong Q2 results featured solid organic sales growth and margin/EPS beats, driven by volume/mix gains in key markets. Increased brand investment and supply chain productivity are expected to support continued growth, despite divestiture and inventory headwinds.
-
Mid-single-digit organic sales growth and double-digit profit gains marked the first half, driven by innovation, productivity, and transformation initiatives. Raised full-year profit outlook, despite ongoing headwinds from currency and divestitures.
-
Leaders outlined a strategy focused on innovation, premiumization, and operational efficiency, targeting significant cost savings and growth in core categories. The organization is shifting to a more connected, focused structure, aiming for consistent double-digit shareholder returns.